Get our monthly newsletter

Follow us on social media

CEO reviews recent developments in the Commission's approach to the revolving door.

As MEPs prepare to quiz Jonathan Hill again, the UK commissioner-designate allocated the portfolio of financial services, and Hill refuses to answer MEPs' question about his former financial lobby clients, Corporate Europe Observatory (CEO) exposes further information about Hill's career as a lobbyist.
In the run-up to the European parliament hearings with the commissioners-designate, Corporate Europe Observatory (CEO) shows how the candidates from Portugal, Latvia and the Czech Republic have serious questions to answer regarding possible conflicts of interest and their recent career or political backgrounds.

David Cameron's nomination of a revolving door ex-lobbyist, Jonathan Hopkin Hill, as EU commissioner is bad news for Jean-Claude Juncker's newly-stated commitment to lobby transparency.

Lobby Planet 2017 banner

We pay our taxes, so why don’t corporations? The Big Four are embedded in EU policy-making on tax avoidance and this report concludes that it is time to kick this industry out of EU anti-tax avoidance policy.

Industry lobbyists are spending millions of euros to influence an upcoming EU decision on labelling titanium dioxide – found in everyday products like sunscreen – a “suspected carcinogen”. The lobbying is led by an unregistered trade association and a public relations consultancy; nonetheless, they appear to have the ear of member states and the European Commission.

In her final decision on European Central Bank (ECB) President Mario Draghi’s membership of the Group of Thirty (G30), the European Ombudsman Emily O’Reilly has voiced disappointment about the bank’s reluctance to follow her recommendation to suspend Draghi’s G30 membership and to bar future presidents from joining the group.

Documents released to Corporate Europe Observatory following a Freedom of Information request reveal how pro-biotech lobby platform Public Research Regulation Initiative (PRRI) unites industry, researchers and regulators in ‘like-minded’ groups to influence crucial international biosafety talks under the UN Convention on Biological Diversity (CBD).